TELA Bio to Announce Third Quarter 2024 Financial Results
TELA Bio, Inc. (NASDAQ: TELA), a commercial-stage medical technology company specializing in soft-tissue reconstruction solutions, has announced it will report its third quarter 2024 financial results on Thursday, November 7, 2024. The company's management will host a conference call and webcast at 4:30 p.m. ET on the same day to discuss the financial results and provide a corporate update.
Investors interested in participating in the conference call are required to register online at least a day in advance or a minimum of 15 minutes before the call starts. A live webcast and replay of the event will be accessible through the Events & Presentations page in the investor section of TELA Bio's website.
TELA Bio, Inc. (NASDAQ: TELA), un'azienda di tecnologia medica in fase commerciale specializzata in soluzioni per la ricostruzione dei tessuti molli, ha annunciato che riporterà i propri risultati finanziari del terzo trimestre 2024 il giovedì 7 novembre 2024. Il management dell'azienda ospiterà una chiamata in conferenza e un webcast alle 16:30 ET lo stesso giorno per discutere i risultati finanziari e fornire un aggiornamento aziendale.
Gli investitori interessati a partecipare alla chiamata in conferenza devono registrarsi online con almeno un giorno di anticipo o un minimo di 15 minuti prima dell'inizio della chiamata. Un webcast dal vivo e la registrazione dell'evento saranno accessibili tramite la pagina Eventi e Presentazioni nella sezione investitori del sito web di TELA Bio.
TELA Bio, Inc. (NASDAQ: TELA), una empresa de tecnología médica en etapa comercial especializada en soluciones de reconstrucción de tejidos blandos, ha anunciado que informará sobre sus resultados financieros del tercer trimestre de 2024 el jueves 7 de noviembre de 2024. La dirección de la empresa llevará a cabo una llamada y webcast a las 4:30 p.m. ET el mismo día para discutir los resultados financieros y proporcionar una actualización corporativa.
Los inversores interesados en participar en la llamada deben registrarse en línea con al menos un día de antelación o un mínimo de 15 minutos antes de que comience la llamada. Se podrá acceder a un webcast en vivo y a la repetición del evento a través de la página de Eventos y Presentaciones en la sección de inversores del sitio web de TELA Bio.
텐라 바이오(TELA Bio, Inc.) (NASDAQ: TELA)는 연조직 재건 솔루션을 전문으로 하는 상업 단계의 의료 기술 회사로, 2024년 3분기 재무 결과를 2024년 11월 7일 목요일에 발표할 것이라고 발표했습니다. 회사의 경영진은 같은 날 오후 4시 30분 ET에 재무 결과를 논의하고 기업 업데이트를 제공하기 위해 컨퍼런스 콜과 웹캐스트를 진행할 예정입니다.
컨퍼런스 콜에 참여하려는 투자자는 하루 전에 온라인으로 등록하거나 통화 시작 최소 15분 전에 등록해야 합니다. 라이브 웹캐스트 및 이벤트 녹화는 TELA Bio 웹사이트 투자자 섹션의 이벤트 및 프레젠테이션 페이지를 통해 접근할 수 있습니다.
TELA Bio, Inc. (NASDAQ: TELA), une entreprise de technologie médicale en phase commerciale spécialisée dans les solutions de reconstruction des tissus mous, a annoncé qu'elle publiera ses résultats financiers du troisième trimestre 2024 le jeudi 7 novembre 2024. La direction de l'entreprise animera une conférence téléphonique et un webémission à 16h30 ET le même jour pour discuter des résultats financiers et fournir une mise à jour sur la société.
Les investisseurs intéressés à participer à la conférence téléphonique doivent s'inscrire en ligne au moins un jour à l'avance ou un minimum de 15 minutes avant le début de l'appel. Un webémission en direct et un replay de l'événement seront accessibles via la page Événements et Présentations dans la section investisseurs du site internet de TELA Bio.
TELA Bio, Inc. (NASDAQ: TELA), ein medizinisches Technologieunternehmen in der Kommerzialisierungsphase, das auf Lösungen zur Rekonstruktion von Weichgewebe spezialisiert ist, hat angekündigt, dass es seine Finanzergebnisse für das dritte Quartal 2024 am Donnerstag, den 7. November 2024, bekannt geben wird. Das Management des Unternehmens wird am selben Tag um 16:30 Uhr ET eine Konferenzschaltung und einen Webcast abhalten, um die Finanzergebnisse zu diskutieren und ein Unternehmensupdate zu geben.
Investoren, die an der Konferenzschaltung teilnehmen möchten, müssen sich mindestens einen Tag im Voraus oder mindestens 15 Minuten vor Beginn der Schaltung online registrieren. Ein Live-Webcast und eine Wiederholung der Veranstaltung werden über die Seite „Veranstaltungen & Präsentationen“ im Investorenbereich der TELA Bio-Website zugänglich sein.
- None.
- None.
MALVERN, Pa., Oct. 17, 2024 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA Bio") (NASDAQ: TELA), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions, today announced that the Company will report third quarter 2024 financial results on Thursday, November 7, 2024. TELA Bio’s management will host a conference call and webcast at 4:30 p.m. ET that day to discuss the financial results and provide a corporate update.
Third Quarter Earnings Conference Call and Webcast Details
Investors interested in listening to the conference call should register online. Participants are required to register a day in advance or at minimum 15 minutes before the start of the call. A live webcast and replay can be accessed via the Events & Presentations page of the investor section of TELA's website.
About TELA Bio, Inc.
TELA Bio, Inc. (NASDAQ: TELA) is a commercial-stage medical technology company focused on providing innovative technologies that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's own anatomy. The Company is committed to providing surgeons with advanced, economically effective soft-tissue reconstruction solutions that leverage the patient's natural healing response while minimizing long-term exposure to permanent synthetic materials. For more information, visit www.telabio.com.
Caution Regarding Forward-Looking Statements
This press release contains forward-looking statements within the meaning of The Private Securities Litigation Reform Act of 1995. Words such as "may," "might," "will," "should," "believe," "expect," "anticipate," "estimate," "continue," "predict," "forecast," "project," "plan," "intend" or similar expressions, or statements regarding intent, belief, or current expectations are forward-looking statements and reflect the current beliefs of TELA Bio's management. These statements are not guarantees of future performance and are subject to certain risks, uncertainties and other factors that could cause actual results and events to differ materially and adversely from those indicated by such forward-looking statements. These risks and uncertainties are described more fully in the "Risk Factors" section and elsewhere in our filings with the Securities and Exchange Commission and available at www.sec.gov, including in our Annual Report on Form 10-K and Quarterly Reports on Form 10-Q. Any forward-looking statements that we make in this announcement speak only as of the date of this press release, and TELA Bio assumes no obligation to update forward-looking statements whether as a result of new information, future events or otherwise after the date of this press release, except as required under applicable law.
Investor Contact
Greg Chodaczek
347-620-7010
ir@telabio.com
FAQ
When will TELA Bio (TELA) report its Q3 2024 financial results?
What time is TELA Bio's (TELA) Q3 2024 earnings conference call?
How can investors participate in TELA Bio's (TELA) Q3 2024 earnings call?
Where can I access the webcast for TELA Bio's (TELA) Q3 2024 earnings call?
